featured
Cancer Treatment May Impact Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
JAMA Oncol 2021 May 28;[EPub Ahead of Print], A Massarweh, N Eliakim-Raz, A Stemmer, A Levy-Barda, S Yust-Katz, A Zer, A Benouaich-Amiel, H Ben-Zvi, N Moskovits, B Brenner, J Bishara, D Yahav, B Tadmor, T Zaks, SM StemmerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.